May 1, 2012 — The fluoroquinolone antibiotic levofloxacin (Levaquin, Janssen Pharmaceuticals Inc) has been approved as part of a US Food and Drug Administration (FDA) priority review application for ...

Andrew F. Shorr, Neringa Zadeikis, William L. Jackson, Anthony S. Ramage, Shu-Chen Wu, Alan M. Tennenberg, Marin H. Kollef Clinical Infectious Diseases, Vol. 40, Supplement 2. The Effective Use of ...

This study tested whether levofloxacin, at a new high dose of 750 mg, was effective for the treatment of complicated skin and skin-structure infections (SSSIs). Patients with complicated SSSIs (n = ...

A 3-month course of levofloxacin does not prevent BK viruria after kidney transplantation but does increase the risk of adverse events, according to data from a new study. “Quinolone prophylaxis was ...

A detailed description of the patients and methodology for tigecycline study 308 are described elsewhere. [22] In brief, a Phase 3, multicenter, randomized, double-blind (third party unblinded) ...

To the Editor: Davidson et al. (March 7 issue) 1 describe four patients with pneumococcal pneumonia in whom therapy with oral levofloxacin failed. We report on a patient with pneumococcal pneumonia ...

Currently there is no standard uniformly accepted treatment of giving antibiotic prophylaxis to children and adults with acute lymphoblastic leukemia (ALL) because there have been no clinical data or ...

Two landmark clinical trials involving researchers at University College London (UCL) have demonstrated that levofloxacin is the first effective treatment to prevent multidrug-resistant tuberculosis ...

Federal drug regulators are considering approving Johnson & Johnson’s powerful antibiotic Levaquin as a treatment for pneumonic plague, the ancient and deadly disease still feared for its potential ...

Hardly anyone succumbs to the bubonic plague these days, but health authorities on Friday approved a new treatment for it and other forms of the potentially deadly bacterial infection. Levaquin, ...

A recent report published in the Journal of Pharmacy Practice describes the case of a 75-year-old female patient who developed acquired hemophilia following levofloxacin administration and then ...

SAN DIEGO, CA—The combination of ceftolozane and tazobactam showed comparable outcomes to levofloxacin in the treatment of complicated pyelonephritis, according to results from the Phase 3 ASEPCT-cUTI ...